Engineered heart tissue: high throughput platform for dissection of complex diseases
- PMID: 20559925
- DOI: 10.1007/s12265-008-9026-0
Engineered heart tissue: high throughput platform for dissection of complex diseases
Abstract
The polygenic nature of resistance/sensitivity of the heart to ischemia is generally accepted. Unfortunately, little is known about gene(s) involved in response to this insult. The goal of present study is to introduce new tool, engineered heart tissue (EHT), for accelerating positional cloning and for providing novel functional assays.
Similar articles
-
Protection by the NO-Donor SNAP and BNP against Hypoxia/Reoxygenation in Rat Engineered Heart Tissue.PLoS One. 2015 Jul 6;10(7):e0132186. doi: 10.1371/journal.pone.0132186. eCollection 2015. PLoS One. 2015. PMID: 26147889 Free PMC article.
-
Engineered heart tissue: a novel tool to study the ischemic changes of the heart in vitro.PLoS One. 2010 Feb 17;5(2):e9275. doi: 10.1371/journal.pone.0009275. PLoS One. 2010. PMID: 20174664 Free PMC article.
-
Piezo-bending actuators for isometric or auxotonic contraction analysis of engineered heart tissue.J Tissue Eng Regen Med. 2019 Jan;13(1):3-11. doi: 10.1002/term.2755. Epub 2018 Nov 26. J Tissue Eng Regen Med. 2019. PMID: 30334614
-
Cardioprotection in stunned and hibernating myocardium.Heart Fail Rev. 2007 Dec;12(3-4):307-17. doi: 10.1007/s10741-007-9040-3. Heart Fail Rev. 2007. PMID: 17541819 Review.
-
Genomics in cardiac metabolism.Cardiovasc Res. 2008 Jul 15;79(2):218-27. doi: 10.1093/cvr/cvn061. Epub 2008 Mar 7. Cardiovasc Res. 2008. PMID: 18326557 Review.